PHARMOCANN GLOBAL (Israel) Today

PHARMOCANN GLOBAL is trading at 128.90 as of the 28th of September 2021, a -2.13 percent decrease since the beginning of the trading day. The stock's open price was 131.699997. Equity ratings for PHARMOCANN GLOBAL are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of June 2021 and ending today, the 28th of September 2021. Click here to learn more.
Valuation
Check how we calculate scores

PHARMOCANN GLOBAL Stock Profile

Pharmocann Global Ltd engages in cultivation of cannabis for medical purposes. The company was founded in 2008 and is based in Raanana, Israel. PHARMOCANN GLOBAL is traded on Tel Aviv Stock Exchange in Israel. more on PHARMOCANN GLOBAL
PHARMOCANN GLOBAL is not yet fully synchronised with the market data
PHARMOCANN GLOBAL has accumulated about 12.3 M in cash with (1.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19.
Roughly 58.0% of the company outstanding shares are owned by corporate insiders
Legal NamePHARMOCANN GLOBAL
CEOGil Hovesh  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of PHARMOCANN GLOBAL's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
PHARMOCANN GLOBAL (PMCN) is traded on Tel Aviv Stock Exchange in Israel and employs 15 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 9.26 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PHARMOCANN GLOBAL's market, we take the total number of its shares issued and multiply it by PHARMOCANN GLOBAL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. PHARMOCANN GLOBAL operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 67.88 M outstanding shares. PHARMOCANN GLOBAL has accumulated about 12.3 M in cash with (1.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19.
Check PHARMOCANN GLOBAL Probability Of Bankruptcy

PHARMOCANN Stock Against Markets

Picking the right benchmark for PHARMOCANN GLOBAL stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in PHARMOCANN GLOBAL stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for PHARMOCANN GLOBAL is critical whether you are bullish or bearish towards PHARMOCANN GLOBAL at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PHARMOCANN GLOBAL stock to make a market-neutral strategy. Peer analysis of PHARMOCANN GLOBAL could also be used in its relative valuation, which is a method of valuing PHARMOCANN GLOBAL by comparing valuation metrics with similar companies.

PHARMOCANN GLOBAL Corporate Management

Elected by the shareholders, the PHARMOCANN GLOBAL's board of directors comprises two types of representatives: PHARMOCANN GLOBAL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PHARMOCANN. The board's role is to monitor PHARMOCANN GLOBAL's management team and ensure that shareholders' interests are well served. PHARMOCANN GLOBAL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PHARMOCANN GLOBAL's outside directors are responsible for providing unbiased perspectives on the board's policies.
Yehuda Peretz - Head Security Officer at Pharmocann Ltd.Profile
Keren Tzlill - External DirectorProfile
Daniel Spira - Internal AuditorProfile
Dan Gillerman - Chairman of the BoardProfile
Liran Halfon - DirectorProfile
Yosef Alharal - External DirectorProfile
Please check Your Equity Center. Note that the PHARMOCANN GLOBAL information on this page should be used as a complementary analysis to other PHARMOCANN GLOBAL's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Tools for PHARMOCANN Stock

When running PHARMOCANN GLOBAL price analysis, check to measure PHARMOCANN GLOBAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PHARMOCANN GLOBAL is operating at the current time. Most of PHARMOCANN GLOBAL's value examination focuses on studying past and present price action to predict the probability of PHARMOCANN GLOBAL's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move PHARMOCANN GLOBAL's price. Additionally, you may evaluate how the addition of PHARMOCANN GLOBAL to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go